<DOC>
	<DOCNO>NCT00002466</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug combine chemotherapy radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy follow radiation therapy treat patient peripheral neuroectodermal tumor , Ewing 's sarcoma , Wilms ' tumor , bone cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Radiation Therapy Treating Patients With Peripheral Neuroectodermal Tumors , Ewing 's Sarcoma , Wilms ' Tumor , Bone Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate event-free survival patient peripheral primitive neuroectodermal tumor Ewing 's sarcoma treat cyclophosphamide , doxorubicin , vincristine , etoposide , ifosfamide , follow surgery ( feasible ) radiotherapy . II . Determine response uniform treatment regimen order clarify whether disease category different prognosis . OUTLINE : Patients stratify accord disease category ( primitive neuroectodermal tumor v Ewing 's sarcoma ) . Patients receive treatment regimen A outlined course 1-3 6 regimen B outline course 4 , 5 , 7 absence disease progression unacceptable toxicity . Each course last 3-4 week . Patients without metastatic disease completion course 3 undergo complete tumor resection , feasible . Patients achieve complete response without microscopic residual disease completion course 7 undergo radiotherapy twice daily , 5 day week , 3 week . Patients gross residual disease completion course 7 undergo radiotherapy twice daily , 5 day week , 3.6 week . Regimens A B define : Regimen A : Patients receive cyclophosphamide IV 6 hour day 1 2 , doxorubicin IV continuously vincristine IV continuously day 1-3 , vincristine IV day 9 . Regimen B : Patients receive etoposide IV 1 hour , follow immediately ifosfamide IV 1 hour day 1-5 . Patients follow monthly 18 month every 6 month 18 month . PROJECTED ACCRUAL : A maximum 50 patient ( 25 per stratum ) accrue study within 5 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis peripheral primitive neuroectodermal tumor , include peripheral neuroepithelioma Askin tumor OR Diagnosis localize metastatic Ewing 's sarcoma , include follow : Unresectable metastatic small cell osteosarcoma Unresectable metastatic nonrhabdomyosarcomatous softtissue sarcoma Unresectable metastatic nonosteosarcomatous bone sarcomas Desmoplastic small roundcell tumor Metastatic nonmetastatic Wilms ' tumor Immunocytochemistry , electron microscopy , and/or chromosomal analysis may require rule small round cell neoplasm PATIENT CHARACTERISTICS : Age : Any age Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>localize osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>childhood desmoplastic small round cell tumor</keyword>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>Askin tumor</keyword>
	<keyword>peripheral primitive neuroectodermal tumor</keyword>
</DOC>